Taken together, our data identify CD142 and podoplanin as potential surface markers that are differentially expressed between cells with mutant, active beta-catenin and nonmutant, inactive beta-catenin in heterogeneous desmoid tumor samples. The gene discussed is F3; the disease is neoplasm.